Economic impact of applying the AASLD-IDSA simplified treatment algorithm on the real-world management of hepatitis C.
Majethia S, Lee IH, Chastek B, Bunner S, Wolf J, Hsiao A, Mozaffari E.
Majethia S, et al. Among authors: chastek b.
J Manag Care Spec Pharm. 2022 Jan;28(1):48-57. doi: 10.18553/jmcp.2021.21246. Epub 2021 Oct 22.
J Manag Care Spec Pharm. 2022.
PMID: 34677088
Continuous enrollment 12 months before and 6 months after index date was required. Patients with claims for hepatitis B, HIV, decompensated liver, or prior DAAs were excluded. Patients were propensity score-matched (1:1) and grouped as "simplified" or "nonsimplified." ...M …
Continuous enrollment 12 months before and 6 months after index date was required. Patients with claims for hepatitis B, HIV, decompe …